/

Takayuki Kimura1, Daisuke Abe1, Mutsukazu Kitano1

  • 1Department of Otolaryngology-Head and Neck Surgery, Kindai University, Faculty of Medicine, Osaka-Sayama, Japan.

PubMed
まとめ

サルコペニア,または筋肉の喪失は,免疫チェックポイント阻害剤を投与された頭頸がん患者で,より悪い結果と関連しています. サルコペニアの治療は,再発性および転移性頭頸部状細胞癌の治療効果を向上させる可能性があります.

関連する概念動画

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
448
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K